Julie Segre

Julie A. Segre
Photo of Julie Segre
Julie A. Segre, Ph.D. Senior Investigator, National Human Genome Research Institute (NHGRI), National Institutes of Health (NIH).
Born
Berkeley, California, U.S.
Alma mater
Known for
  • Foundational studies of the human skin associated microbes (bacteria, fungi, viruses)skin flora[1]
  • Using DNA sequencing to track antibiotic-resistant bacteria in hospitals.

[2]

  • NIH 'superbug' was thwarted with help of two scientists

[3]

Scientific career
Fields
  • Microbial Genomics
  • Genetics and Molecular Biology
Institutions
Academic advisorsEric Lander, Elaine Fuchs

Julie Angela Segre is the Chief and Senior Investigator of the Translational and Functional Genomics Branch in the National Human Genome Research Institute at the National Institutes of Health.[4] She was elected to the National Academy of Medicine in 2019,[5] the American Academy of Arts and Sciences in 2020[6] and the National Academy of Sciences in 2022.[7]

  1. ^ Byrd, A. L.; Belkaid, Y.; Segre, J. A. (2018). "The human skin microbiome". Nature Reviews. Microbiology. 16 (3): 143–155. doi:10.1038/nrmicro.2017.157. PMID 29332945. S2CID 46781506.
  2. ^ Zimmer, Carl. "How Scientists Stalked a Lethal Superbug—With the Killer's Own DNA". Wired.
  3. ^ "NIH 'superbug' was thwarted with help of two scientists". The Washington Post.
  4. ^ "Julie Segre biography".
  5. ^ "National Academy of Medicine". 21 October 2019.
  6. ^ "New Members". American Academy of Arts & Sciences. Retrieved 2020-04-23.
  7. ^ "National Academy of Sciences". 3 May 2022.